ArticleCancer research communications2024

Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.

Nitin Roper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.